2016, Number S1
<< Back Next >>
Rev Mex Anest 2016; 39 (S1)
Management of the glial response in the treatment of chronic pain
Ochoa-Aguilar A, Nuche-Cabrera E
Language: Spanish
References: 7
Page: 14-15
PDF size: 132.86 Kb.
Text Extraction
No abstract.
REFERENCES
Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10:23-36.
Koltzenburg M, McMahon SB, Tracey I, Turk DC. Wall & Melzack’s Textbook of Pain. Louis, MO: Elsevier Health Sciences; 2013.
Palazzo E, Luongo L, de Novellis V, Rossi F, Marabese I, Maione S. Transient receptor potential vanilloid type 1 and pain development. Curr Opin Pharmacol. 2012;12:9-17.
Sałat K, Kowalczyk P, Gryzło B, Jakubowska A, Kulig K. New investigational drugs for the treatment of neuropathic pain. Expert Opin Investig Drugs. 2014;23:1093-1104.
Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur J Pharmacol. 2013;716: 61-76.
Vanelderen P, Van Zundert J, Kozicz T, Puylaert M, De Vooght P, Mestrum R, et al. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Anesthesiology. 2015,;122:399-406.
Albert HB, Sorensen JS, Christensen BS, Manniche C. Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy. Eur Spine J. 2013;22:697-707.
Full text